9
Nov
2015
EPO patent
Immunicum AB (publ) reported today that the European Patent Office (EPO), has announced that it intends to grant a patent relating to the Company’s cancer immune primer, INTUVAX.
Read the press release here: Press release 151109 – patent EPO